101 related articles for article (PubMed ID: 2482319)
1. [Analysis of the treatment of pseudomyxoma peritonei--cytoreductive surgery with chemotherapy and intraperitoneal inoculation after washing with dextran].
Kataoka A; Nishida T; Sugiyama T; Yakushiji M
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2394-9. PubMed ID: 2482319
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological study of pseudomyxoma peritonei].
Kataoka A; Yakushiji M; Sugiyama T; Nishida T; Nagasue N; Kawano K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1769-75. PubMed ID: 2480394
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.
Järvinen P; Ristimäki A; Kantonen J; Lepistö A
Scand J Surg; 2013; 102(3):145-51. PubMed ID: 23963027
[TBL] [Abstract][Full Text] [Related]
4. [Three cases of Pseudomyxoma peritonei treated with intraperitoneal inoculation of cisplatin through an implantable port system].
Suzuki T; Umekita N; Inoue S; Miyamoto S; Maeshiro T; Awane Y
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1449-51. PubMed ID: 9703851
[TBL] [Abstract][Full Text] [Related]
5. [Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Smeenk RM; Verwaal VJ; Zoetmulder FA
Ned Tijdschr Geneeskd; 2007 Feb; 151(7):418-23. PubMed ID: 17343142
[TBL] [Abstract][Full Text] [Related]
6. Cytoreduction including total gastrectomy for pseudomyxoma peritonei.
Sugarbaker PH
Br J Surg; 2002 Feb; 89(2):208-12. PubMed ID: 11856136
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
Loungnarath R; Causeret S; Bossard N; Faheez M; Sayag-Beaujard AC; Brigand C; Gilly F; Glehen O
Dis Colon Rectum; 2005 Jul; 48(7):1372-9. PubMed ID: 15909071
[TBL] [Abstract][Full Text] [Related]
9. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study.
Jess P; Iversen LH; Nielsen MB; Hansen F; Laurberg S; Rasmussen PC
Dis Colon Rectum; 2008 Jun; 51(6):868-74. PubMed ID: 18297361
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
11. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.
Chua TC; Yan TD; Smigielski ME; Zhu KJ; Ng KM; Zhao J; Morris DL
Ann Surg Oncol; 2009 Jul; 16(7):1903-11. PubMed ID: 19387742
[TBL] [Abstract][Full Text] [Related]
13. [A case of pseudomyxoma peritonei treated successfully with intraperitoneal administration of CBDCA and etoposide, followed by local delivery of dextran with CDDP during surgery].
Shiraishi S; Sakurai N; Tanaka Y; Iwahashi K; Kitaoka Y
Gan To Kagaku Ryoho; 2001 Aug; 28(8):1155-7. PubMed ID: 11525036
[TBL] [Abstract][Full Text] [Related]
14. [A case report of malignant pseudomyxoma peritonei treated by a new modality of intraperitoneal chemo-hyperthermia].
Kishimoto S; Kameyama M; Kodama K; Nakamori S; Ohigashi H; Hiratsuka M; Sasaki Y; Ishikawa O; Kabuto T; Furukawa H
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1703-6. PubMed ID: 8373254
[TBL] [Abstract][Full Text] [Related]
15. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved.
Dayal S; Taflampas P; Riss S; Chandrakumaran K; Cecil TD; Mohamed F; Moran BJ
Dis Colon Rectum; 2013 Dec; 56(12):1366-72. PubMed ID: 24201390
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
Hsu KH; Chou CY; Chang YC
Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
[TBL] [Abstract][Full Text] [Related]
17. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gómez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; González-Moreno S; Van Der Speeten K; Morris DL
J Clin Oncol; 2012 Jul; 30(20):2449-56. PubMed ID: 22614976
[TBL] [Abstract][Full Text] [Related]
18. Pseudomyxoma peritonei: treatment with intraperitoneal 5-fluorouracil.
Nasr MF; Kemp GM; Given FT
Eur J Gynaecol Oncol; 1993; 14(3):213-7. PubMed ID: 8508878
[TBL] [Abstract][Full Text] [Related]
19. Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation.
Chua TC; Al-Zahrani A; Saxena A; Liauw W; Zhao J; Morris DL
J Am Coll Surg; 2010 Oct; 211(4):526-35. PubMed ID: 20729102
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: aspects of the learning curve.
Andréasson H; Lorant T; Påhlman L; Graf W; Mahteme H
Eur J Surg Oncol; 2014 Aug; 40(8):930-6. PubMed ID: 24656455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
